Homozygous familial hypobetalipoproteinemia: Increased LDL catabolism in hypobetalipoproteinemia due to a truncated apolipoprotein B species, apo B- 87(Padova)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 9, 1996, Pages 1189-1196

  Gabelli, Carlo ^a   Bilato, Claudio ^a   Martini, Scipione ^a   Tennyson, Gregory E ^b   Zech, Loren A ^b   Corsini, Alberto ^c   Albanese, Marco ^a   Bryan Brewer Jr , H ^b   Crepaldi, Gaetano ^a   Baggio, Giovannella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

apolipoprotein B; atherosclerosis; cholesterol metabolism; lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HYPOBETALIPOPROTEINEMIA; LIPOPROTEIN METABOLISM; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

EID: 9544250371     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.9.1189     Document Type: Article

References (35)

1. Kane JP, Havel RJ. Disorder of biogenesis and secretion of lipoproteins containing the B apolipoprotein. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill Publishing Co; 1989:1139-1164.
2. Muller DPR, Lloyd JK, Wolf OH. Vitamin E and neurologic function. Lancet. 1983;1:225-228.
3. Linton MF, Farese VF Jr, Young SG. Familial hypobetalipoproteinemia. J Lipid Res. 1993;34:521-541.
4. Gabelli C. The lipoprotein metabolism of apolipoprotein B mutants. Curr Opin Lipidol. 1992;3:208-214.
5. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
6. Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methoden der Enzymatischen Analyse. 3rd ed. Weinheim, Germany: Verlag Chemie; 1974:1878-1982.
7. Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Z Klin Chem Klin Biochem. 1974;12:403-407.
8. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
9. Bojanovski MR, Gregg RE, Wilson DM, Brewer HB Jr. Semiautomated enzyme-linked immunosorbent assay (ELISA) for the quantitation of apolipoprotein B using monoclonal antibodies. Clin Chim Acta. 1987;170:281-290.
10. Warnick GR, Mayfield C, Albers JJ, Hazzard WR. Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem. 1979;25:279-284.
11. 1J. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
12. Gabelli C, Stark DG, Gregg RE, Brewer HB Jr. Separation of apolipoprotein B species by agarose-acrylamide gel electrophoresis. J Lipid Res. 1986;27:457-460.
13. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
14. Marcel YM, Innerarity TL, Spilman C, Mahley RW, Protter AA, Milne RW. Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis. 1987;7:166-175.
15. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
16. Manzato E, Zambon S, Zambon A, Cortella A, Sartore G, Crepaldi G, Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. Clin Chim Acta. 1993;218:57-65.
17. Sambrook H, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
18. Saiki RK, Gelfand DH, Stoffel S, Sharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science. 1988;239:487-491.
19. Sanger F, Nicklen S, Coulsen AR, DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463-5467.
20. Mitchell LG, Merill CR. Affinity generation of single-stranded DNA for dideoxy sequencing following the polymerase chain reaction. Anal Biochem. 1989;178:239-242.
21. MacFarlane AS. Efficient trace-labeling of proteins with iodine. Nature. 1958;182:53.
22. Gabelli C, Gregg RE, Zech LA, Manzato E, Brewer HB Jr. Abnormal low density lipoprotein metabolism in apolipoprotein E deficiency. J Lipid Res. 1986;27:326-333.
23. Berman M, Weiss M. SAAM Manual. Bethesda, MD: US Dept of Health, Education, and Welfare publication NIH 78-180;1977:1-198.
24. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low density lipoproteins in cultured cells. Methods Enzymol. 1982;98:241-260.
25. Corsini A, Roma P, Sommariva D, Fumagalli R, Catapano AL. Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia. J Clin Invest. 1986;78:940-946.
26. Fisher RA, Yates F. Statistical Tables for Agricultural and Medical Research. 4th ed. Edinburgh, Scotland: Oliver & Boyd; 1953:1-60.
27. Huang LS, Ripps ME, Korman SH, Deckelbaum RJ, Breslow JL. Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem. 1989;264:11394-11400.
28. Hardman DA, Pullinger CR, Hamilton RL, Kane JP, Malloy MJ. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J Clin Invest, 1991;88:1722-1729.
29. Malloy MJ, Kane JP, Hardman DA, Hamilton RL, Dalal KB. Normotriglyceridemic abetalipoproteinemia: absence of the B-100 apolipoprotein. J Clin Invest. 1981;67:1441-1450.
30. Young SG, Bihain B, Flynn LM, Sanan DA, Ayrault-Jarrier M, Jacotot B. Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum Mol Genet. 1994;3:741-744.
31. Parhofer KG, Barret PHR, Aguilar-Salinas CA, Richter WO, Schonfeld G. The length of truncated apolipoprotein B correlates linearly with its in vivo secretion rate. Circulation. 1994;90(suppl I):I-185. Abstract.
32. Parhofer KG, Barret PHR, Bier DM, Schonfeld G. Lipoproteins containing the truncated apolipoprotein, apo B-89, are cleared from human plasma more rapidly than apo B-100-containing lipoprotein in vivo. J Clin Invest. 1992;89:1931-1937.
33. Krul ES, Kinoshita M, Talmud P, Humphries SE, Turner S, Goldberg AC, Cook K, Boerwinkle E, Schonfeld G. Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis. 1989;9:856-868.
34. Fantappiè S, Corsini A, Sidoli A, Uboldi P, Granata A, Zanelli T, Rossi P, Marcovina S, Fumagalli R, Catapano AL. Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B-100 relevant to low density lipoprotein-receptor interaction. J Lipid Res. 1992;33:1111-1121.
35. Chappell DA, Fry GL, Waknitz MA, Berns JJ. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway: a lattice model for LDL binding. J Biol Chem. 1991;266:19296-19302.